Current HIV/AIDS Reports

, Volume 9, Issue 4, pp 351–363 | Cite as

Interventions to Address Chronic Disease and HIV: Strategies to Promote Exercise and Nutrition Among HIV-Infected Individuals

  • Diana Botros
  • Gabriel Somarriba
  • Daniela Neri
  • Tracie L. Miller
Behavioral Aspects of HIV Management (RJ DiClemente and JL Brown, Section Editors)


Food insecurity, micronutrient deficits, dyslipidemia, insulin resistance, obesity, cardiovascular disease, and bone disorders complicate the treatment of HIV infection. Nutrition and exercise interventions can be effective in ameliorating these symptoms that are associated with HIV and antiretroviral therapy (ART). In this literature review, we examine the most recent nutrition and exercise interventions for HIV-infected patients. Macronutrient supplementation can be useful in treating malnutrition and wasting. Multivitamin (vitamin B complex, vitamin C, and vitamin E) supplements and vitamin D may improve quality of life and decrease morbidity and mortality. Nutritional counseling and exercise interventions are effective for treating obesity, fat redistribution, and metabolic abnormalities. Physical activity interventions improve body composition, strength, and fitness in HIV-infected individuals. Taken collectively, the evidence suggests that a proactive approach to nutrition and physical activity guidance and interventions can improve outcomes and help abrogate the adverse metabolic, cardiovascular, and psychological consequences of HIV and its treatments.


HIV Chronic disease and HIV Nutrition Physical activity Interventions Cardiometabolic disease Malnutrition Antiretroviral therapy (ART) Multivitamin supplementation Vitamin D 



This work was supported by grants from National Institutes of Health (NHLBI 1 R01 HL095127, NICHD 1 R01 HD060325, 1R01 NR012885), the Micah Batchelor Award for Research Excellence, and the Coulter Jones Foundation.


No potential conflicts of interest relevant to this article were reported.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Fitch K, Grinspoon S. Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients. Am J Clin Nutr. 2011;94(6):1721S–8S.PubMedCrossRefGoogle Scholar
  2. 2.
    Palella Jr FJ, Phair JP. Cardiovascular disease in HIV infection. Curr Opin HIV AIDS. 2011;6(4):266–71.PubMedCrossRefGoogle Scholar
  3. 3.
    Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, et al. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol. 2012;59(21):1891–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Arbeitman LOBR, Somarriba G, Ludwig D, Messiah S, Neri D, Scott G, Miller T, editors. Prevalence of Obesity in HIV-Infected Children in a Miami Cohort. Boston: Pediatric Academic Societies; 2012 (abstract #450452).Google Scholar
  5. 5.
    Fields-Gardner C, Campa A, American Dietetics A. Position of the American dietetic association: nutrition intervention and human immunodeficiency virus infection. J Am Diet Assoc. 2010;110(7):1105–19.PubMedCrossRefGoogle Scholar
  6. 6.
    Chandra RK. Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. Proc Natl Acad Sci U S A. 1996;93(25):14304–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Hughes S, Kelly P. Interactions of malnutrition and immune impairment, with specific reference to immunity against parasites. Parasite Immunol. 2006;28(11):577–88.PubMedGoogle Scholar
  8. 8.
    Chandrasekhar A, Gupta A. Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? Am J Clin Nutr. 2011;94(6):1703S–15S.PubMedCrossRefGoogle Scholar
  9. 9.
    Raiten DJ. Nutrition and pharmacology: general principles and implications for HIV. Am J Clin Nutr. 2011;94(6):1697S–702S.PubMedCrossRefGoogle Scholar
  10. 10.
    Raiten DJ, Mulligan K, Papathakis P, Wanke C. Executive summary--nutritional care of HIV-infected adolescents and adults, including pregnant and lactating women: what do we know, what can we do, and where do we go from here? Am J Clin Nutr vol 6. United States 2011. p. 1667S-76S.Google Scholar
  11. 11.
    Ivers LC, Cullen KA. Food insecurity: special considerations for women. Am J Clin Nutr. 2011;94(6):1740S–4S.PubMedCrossRefGoogle Scholar
  12. 12.
    Kosmiski L. Energy expenditure in HIV infection. Am J Clin Nutr. 2011;94(6):1677S–82S.PubMedCrossRefGoogle Scholar
  13. 13.
    Musoke PM, Fergusson P. Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings. Am J Clin Nutr. 2011;94(6):1716S–20S.PubMedCrossRefGoogle Scholar
  14. 14.
    Weiser SD, Young SL, Cohen CR, Kushel MB, Tsai AC, Tien PC, et al. Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS. Am J Clin Nutr. 2011;94(6):1729S–39S.PubMedCrossRefGoogle Scholar
  15. 15.
    Larson NI, Story MT. Food insecurity and weight status among U.S. children and families: a review of the literature. Am J Prev Med. 2011;40(2):166–73.PubMedCrossRefGoogle Scholar
  16. 16.
    Bahwere P, Deconinck H, Banda T, Mtimuni A, Collins S. Impact of household food insecurity on the nutritional status and the response to therapeutic feeding of people living with human immunodeficiency virus. Patient Prefer Adherence. 2011;5:619–27.PubMedCrossRefGoogle Scholar
  17. 17.
    Yager JE, Kadiyala S, Weiser SD. HIV/AIDS, food supplementation and livelihood programs in Uganda: a way forward? PLoS One. 2011;6(10):e26117.PubMedCrossRefGoogle Scholar
  18. 18.
    Ahoua L, Umutoni C, Huerga H, Minetti A, Szumilin E, Balkan S, et al. Nutrition outcomes of HIV-infected malnourished adults treated with ready-to-use therapeutic food in sub-Saharan Africa: a longitudinal study. J Int AIDS Soc. 2011;14:2.PubMedCrossRefGoogle Scholar
  19. 19.
    Kundu CK, Samanta M, Sarkar M, Bhattacharyya S, Chatterjee S. Food supplementation as an incentive to improve pre-antiretroviral therapy clinic adherence in HIV-positive children–experience from eastern India. J Trop Pediatr. 2012;58(1):31–7.PubMedCrossRefGoogle Scholar
  20. 20.
    • Kayira D, Bentley ME, Wiener J, Mkhomawanthu C, King CC, Chitsulo P, et al. A lipid-based nutrient supplement mitigates weight loss among HIV-infected women in a factorial randomized trial to prevent mother-to-child transmission during exclusive breastfeeding. Am J Clin Nutr. 2012;95(3):759–65. This study reports that a lipid-based supplement diminishes weight loss in HIV-infected pregnant women living in a resource-limited setting. Optimization of maternal nutrition may ultimately impact pregnancy and infant outcomes.PubMedCrossRefGoogle Scholar
  21. 21.
    Kindra G, Coutsoudis A, Esposito F. Effect of nutritional supplementation of breastfeeding HIV positive mothers on maternal and child health: findings from a randomized controlled clinical trial. BMC Public Health. 2011;11:946.PubMedCrossRefGoogle Scholar
  22. 22.
    Hummelen R, Vos AP, van't Land B, van Norren K, Reid G. Altered host-microbe interaction in HIV: a target for intervention with pro- and prebiotics. Int Rev Immunol. 2010;29(5):485–513.PubMedCrossRefGoogle Scholar
  23. 23.
    Hummelen R, Hemsworth J, Changalucha J, Butamanya NL, Hekmat S, Habbema JD, et al. Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients. Nutrients. 2011;3(10):897–909.PubMedCrossRefGoogle Scholar
  24. 24.
    Hummelen R, Changalucha J, Butamanya NL, Koyama TE, Cook A, Habbema JD, et al. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes. 2011;2(2):80–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Irvine SL, Hummelen R, Hekmat S. Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania. Nutr Res. 2011;31(12):875–81.PubMedCrossRefGoogle Scholar
  26. 26.
    Siegfried N, Irlam JH, Visser ME, Rollins NN. Micronutrient supplementation in pregnant women with HIV infection. Cochrane Database Syst Rev. 2012;3:CD009755.PubMedGoogle Scholar
  27. 27.
    WHO. Nutrient Requirements for People Living with HIV/AIDS: Report of a technical consultation. 2003.Google Scholar
  28. 28.
    Forrester JE, Sztam KA. Micronutrients in HIV/AIDS: is there evidence to change the WHO 2003 recommendations? Am J Clin Nutr. 2011;94(6):1683S–9S.PubMedCrossRefGoogle Scholar
  29. 29.
    Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004;351(1):23–32.PubMedCrossRefGoogle Scholar
  30. 30.
    Fawzi WW, Msamanga GI, Kupka R, Spiegelman D, Villamor E, Mugusi F, et al. Multivitamin supplementation improves hematologic status in HIV-infected women and their children in Tanzania. Am J Clin Nutr. 2007;85(5):1335–43.PubMedGoogle Scholar
  31. 31.
    • Kawai K, Kupka R, Mugusi F, Aboud S, Okuma J, Villamor E, et al. A randomized trial to determine the optimal dosage of multivitamin supplements to reduce adverse pregnancy outcomes among HIV-infected women in Tanzania. Am J Clin Nutr. 2010;91(2):391–7. This randomized trial found no difference in the effects of single compared with multiple RDA multivitamin supplements on the risks of adverse pregnancy outcomes among HIV-infected pregnant women. Micronutrient deficiencies and nutrient-nutrient interactions are of great concern to this population of HIV-infected women and their offspring.PubMedCrossRefGoogle Scholar
  32. 32.
    Ndeezi G, Tylleskar T, Ndugwa CM, Tumwine JK. Effect of multiple micronutrient supplementation on survival of HIV-infected children in Uganda: a randomized, controlled trial. J Int AIDS Soc. 2010;13:18.PubMedCrossRefGoogle Scholar
  33. 33.
    Irlam JH, Visser MM, Rollins NN, Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev. 2010(12):CD003650.Google Scholar
  34. 34.
    Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet. 1994;343(8913):1593–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Azais-Braesco V, Pascal G. Vitamin A in pregnancy: requirements and safety limits. Am J Clin Nutr. 2000;71(5 Suppl):1325S–33S.PubMedGoogle Scholar
  36. 36.
    Wiysonge CS, Shey M, Kongnyuy EJ, Sterne JA, Brocklehurst P. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2011(1):CD003648.Google Scholar
  37. 37.
    Bonjoch A, Figueras M, Estany C, Perez-Alvarez N, Rosales J, del Rio L, et al. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS. 2010;24(18):2827–33.PubMedCrossRefGoogle Scholar
  38. 38.
    Ofotokun I, McIntosh E, Weitzmann MN. HIV: inflammation and bone. Curr HIV/AIDS Rep. 2012;9(1):16–25.PubMedCrossRefGoogle Scholar
  39. 39.
    Lagishetty V, Liu NQ, Hewison M. Vitamin D metabolism and innate immunity. Mol Cell Endocrinol. 2011;347(1–2):97–105.PubMedCrossRefGoogle Scholar
  40. 40.
    Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (the Australian diabetes, obesity and lifestyle study: AusDiab). J Clin Endocrinol Metab. 2012;97(6):1953–61.PubMedCrossRefGoogle Scholar
  41. 41.
    Muscogiuri G, Sorice GP, Ajjan R, Mezza T, Pilz S, Prioletta A, et al. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis. 2012;22(2):81–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Adeyemi OM, Agniel D, French AL, Tien PC, Weber K, Glesby MJ, et al. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr. 2011;57(3):197–204.PubMedCrossRefGoogle Scholar
  43. 43.
    Rutstein R, Downes A, Zemel B, Schall J, Stallings V. Vitamin D status in children and young adults with perinatally acquired HIV infection. Clin Nutr. 2011;30(5):624–8.PubMedCrossRefGoogle Scholar
  44. 44.
    •• Viard JP, Souberbielle JC, Kirk O, Reekie J, Knysz B, Losso M, et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS. 2011;25(10):1305–15. This study shows evidence that vitamin D deficiency is an important cofactor in HIV disease progression and this is of importance as vitamin D deficiency is frequent and also associated with morbidity and mortality in this population.PubMedCrossRefGoogle Scholar
  45. 45.
    Mehta S, Mugusi FM, Spiegelman D, Villamor E, Finkelstein JL, Hertzmark E, et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS. 2011;25(10):579–85.PubMedCrossRefGoogle Scholar
  46. 46.
    Ross AC, Judd S, Kumari M, Hileman C, Storer N, Labbato D, et al. Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir Ther. 2011;16(4):555–63.PubMedCrossRefGoogle Scholar
  47. 47.
    Shikuma CM, Seto T, Liang CY, Bennett K, Degruttola V, Gerschenson M, et al. Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses. 2012;28(8):793–7.Google Scholar
  48. 48.
    Sroussi HY, Burke-Miller J, French AL, Adeyemi OM, Weber KM, Lu Y, et al. Association among Vitamin D, Oral Candidiasis, and Calprotectinemia in HIV. J Dent Res. 2012;91(7):666–70.PubMedCrossRefGoogle Scholar
  49. 49.
    Crutchley RD, Gathe Jr J, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses. 2012;28(5):454–9.PubMedGoogle Scholar
  50. 50.
    O'Brien KO, Donangelo CM, Ritchie LD, Gildengorin G, Abrams S, King JC. Serum 1,25-dihydroxyvitamin D and calcium intake affect rates of bone calcium deposition during pregnancy and the early postpartum period. Am J Clin Nutr. 2012;96(1):64–72.PubMedCrossRefGoogle Scholar
  51. 51.
    Kim JH, Gandhi V, Psevdos Jr G, Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res Hum Retroviruses. 2012;28(3):235–41.PubMedCrossRefGoogle Scholar
  52. 52.
    Lai H, Detrick B, Fishman EK, Gerstenblith G, Brinker JA, Hollis BW, et al. Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. J Investig Med. 2012;60(5):801–7.PubMedGoogle Scholar
  53. 53.
    Lai H, Gerstenblith G, Fishman EK, Brinker J, Kickler T, Tong W, et al. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin Infect Dis. 2012;54(12):1747–55.PubMedCrossRefGoogle Scholar
  54. 54.
    Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011;31(1):48–54.PubMedCrossRefGoogle Scholar
  55. 55.
    Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88(2):558S–64S.PubMedGoogle Scholar
  56. 56.
    Childs K, Welz T, Samarawickrama A, Post FA. Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients. AIDS. 2012;26(3):253–62.PubMedCrossRefGoogle Scholar
  57. 57.
    • Havens PL, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, et al. Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin Infect Dis. 2012;54(7):1013–25. This study of over 200 young adults randomized to receive vitamin D or not showed decreases in PTH levels of those one tenofovir, regardless of vitamin D levels at baseline. This suggests that vitamin D supplementation may offset the effect of tenofovir on calcium balance and bone metabolism.PubMedCrossRefGoogle Scholar
  58. 58.
    Longenecker CT, Hileman CO, Carman TL, Ross AC, Seydafkan S, Brown TT, et al. Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther. 2012;17(4):613–21.PubMedCrossRefGoogle Scholar
  59. 59.
    • Kakalia S, Sochett EB, Stephens D, Assor E, Read SE, Bitnun A. Vitamin D supplementation and CD4 count in children infected with human immunodeficiency virus. J Pediatr. 2011;159(6):951–7. This randomized clinical trial concluded that supplementation with 1600 IU of vitamin D per day does not impact CD4 count and suggested that doses above current recommendations may be more appropriate. PubMedCrossRefGoogle Scholar
  60. 60.
    • Arpadi SM, McMahon DJ, Abrams EJ, Bamji M, Purswani M, Engelson ES, et al. Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial. Am J Clin Nutr. 2012;95(3):678–85. This randomized clinical trial concluded that 1g of calcium per day and 100,000 IU oral cholecalciferol every 2 months improves vitamin D serum levels but does not affect bone mass accrual in HIV-infected children and adolescents.PubMedCrossRefGoogle Scholar
  61. 61.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.PubMedCrossRefGoogle Scholar
  62. 62.
    Nunnari G, Coco C, Pinzone MR, Pavone P, Berretta M, Di Rosa M, et al. The role of micronutrients in the diet of HIV-1-infected individuals. Front Biosci (Elite Ed). 2012;4:2442–56.CrossRefGoogle Scholar
  63. 63.
    Baum MK, Lai S, Sales S, Page JB, Campa A. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect Dis. 2010;50(12):1653–60.PubMedCrossRefGoogle Scholar
  64. 64.
    Zeng L, Zhang L. Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review. Trop Med Int Health. 2011. doi: 10.1111/j.1365-3156.2011.02871.x.
  65. 65.
    Kamwesiga J, Mutabazi V, Kayumba J, Tayari JC, Smyth R, Fay H, et al. Effect of selenium supplementation on CD4 T-cell recovery, viral suppression, morbidity and quality of life of HIV-infected patients in Rwanda: study protocol for a randomized controlled trial. Trials. 2011;12:192.PubMedCrossRefGoogle Scholar
  66. 66.
    Stone CA, Kawai K, Kupka R, Fawzi WW. Role of selenium in HIV infection. Nutr Rev. 2010;68(11):671–81.PubMedCrossRefGoogle Scholar
  67. 67.
    Borges-Santos MD, Moreto F, Pereira PC, Ming-Yu Y, Burini RC. Plasma glutathione of HIV(+) patients responded positively and differently to dietary supplementation with cysteine or glutamine. Nutrition. 2012;28(7–8):753–6.PubMedCrossRefGoogle Scholar
  68. 68.
    Geffner ME, Patel K, Miller TL, Hazra R, Silio M, Van Dyke RB, et al. Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study. Horm Res Paediatr. 2011;76(6):386–91.PubMedCrossRefGoogle Scholar
  69. 69.
    Silva EF, Lewi DS, Vedovato GM, Garcia VR, Tenore SB, Bassichetto KC. Nutritional and clinical status, and dietary patterns of people living with HIV/AIDS in ambulatory care in Sao Paulo, Brazil. Rev Bras Epidemiol. 2010;13(4):677–88.PubMedCrossRefGoogle Scholar
  70. 70.
    Souza DT, Rondo PH, Reis LC. The nutritional status of children and adolescents with HIV/AIDS on antiretroviral therapy. J Trop Pediatr. 2011;57(1):65–8.PubMedCrossRefGoogle Scholar
  71. 71.
    •• Miller TI, Borkowsky W, DiMeglio LA, Dooley L, Geffner ME, Hazra R, et al. Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children. HIV Med. 2012;13(5):264–75. This multi-centered study presents the anthropometric, metabolic, inflammatory and endothelial dysfunction abnormalities in children and adolescents with HIV.PubMedCrossRefGoogle Scholar
  72. 72.
    Bonfanti P, De Socio GV, Ricci E, Antinori A, Martinelli C, Vichi F, et al. The feature of metabolic syndrome in HIV naive patients is not the same of those treated: Results from a prospective study. Biomed Pharmacother. 2012;66(5):348–53.Google Scholar
  73. 73.
    Stanley TL, Grinspoon SK. Body composition and metabolic changes in HIV-infected patients. J Infect Dis. 2012;205 Suppl 3:S383–90.PubMedCrossRefGoogle Scholar
  74. 74.
    Miller TL, Somarriba G, Orav EJ, Mendez AJ, Neri D, Schaefer N, et al. Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1. J Acquir Immune Defic Syndr. 2010;55(2):182–8.PubMedCrossRefGoogle Scholar
  75. 75.
    Baker JV, Duprez D. Biomarkers and HIV-associated cardiovascular disease. Curr Opin HIV AIDS. 2010;5(6):511–6.PubMedCrossRefGoogle Scholar
  76. 76.
    Worm SW, Hsue P. Role of biomarkers in predicting CVD risk in the setting of HIV infection? Curr Opin HIV AIDS. 2010;5(6):467–72.PubMedCrossRefGoogle Scholar
  77. 77.
    Sztam KA, Jiang H, Jurgrau A, Deckelbaum RJ, Foca MD. Early increases in concentrations of total, LDL, and HDL cholesterol in HIV-infected children following new exposure to antiretroviral therapy. J Pediatr Gastroenterol Nutr. 2011;52(4):495–8.PubMedCrossRefGoogle Scholar
  78. 78.
    Rhoads MP, Lanigan J, Smith CJ, Lyall EG. Effect of specific ART drugs on lipid changes and the need for lipid management in children with HIV. J Acquir Immune Defic Syndr. 2011;57(5):404–12.PubMedCrossRefGoogle Scholar
  79. 79.
    Jacobson DL, Williams P, Tassiopoulos K, Melvin A, Hazra R, Farley J. Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C study. J Acquir Immune Defic Syndr. 2011;57(5):413–20.PubMedCrossRefGoogle Scholar
  80. 80.
    Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at Accessed 28 June 2012.
  81. 81.
    • Lazzaretti RK, Kuhmmer R, Sprinz E, Polanczyk CA, Ribeiro JP. Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial. J Am Coll Cardiol. 2012;59(11):979–88. This randomized trial of nutritional education through NCEP guidelines showed caloric intake from fat was decreased and resulted in lower levels of triglycerides and a lower percent of patients with dyslipidemia at 1 year post intervention. This is an encouraging study that shows close nutritional monitoring and guidance can be effective in decreased CVD risk among HIV-infected adults.PubMedCrossRefGoogle Scholar
  82. 82.
    Almeida LB, Segurado AC, Duran AC, Jaime PC. Impact of a nutritional counseling program on prevention of HAART-related metabolic and morphologic abnormalities. AIDS Care. 2011;23(6):755–63.PubMedCrossRefGoogle Scholar
  83. 83.
    • Balasubramanyam A, Coraza I, Smith EO, Scott LW, Patel P, Iyer D, et al. Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial. J Clin Endocrinol Metab. 2011;96(7):2236–47. This study of over 200 HIV-infected adults shows that the addition of dietary counseling can improve metabolic outcomes in adults who are on other pharmacologic interventions. This suggests a role of dietary counseling even in those HIV-infected patients who require medications to treat their dyslipidemia.PubMedCrossRefGoogle Scholar
  84. 84.
    Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med. 2007;44(4):335–40.PubMedCrossRefGoogle Scholar
  85. 85.
    Tsiodras S, Poulia KA, Yannakoulia M, Chimienti SN, Wadhwa S, Karchmer AW, et al. Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy. Metabolism. 2009;58(6):854–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Oliveira JM, Rondo PH. Omega-3 fatty acids and hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: systematic review and meta-analysis. HIV Clin Trials. 2011;12(5):268–74.PubMedCrossRefGoogle Scholar
  87. 87.
    Peters BS, Wierzbicki AS, Moyle G, Nair D, Brockmeyer N. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial. Clin Ther. 2012;34(1):67–76.PubMedCrossRefGoogle Scholar
  88. 88.
    Aghdassi E, Arendt BM, Salit IE, Mohammed SS, Jalali P, Bondar H, et al. In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial. Curr HIV Res. 2010;8(2):113–20.PubMedCrossRefGoogle Scholar
  89. 89.
    McComsey GA, O'Riordan M, Choi J, Libutti D, Rowe D, Storer N, et al. Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir. Antivir Ther. 2012;17(2):347–53.PubMedCrossRefGoogle Scholar
  90. 90.
    Cade WT, Peralta L, Keyser RE. Aerobic capacity in late adolescents infected with HIV and controls. Pediatr Rehabil. 2002;5(3):161–9.PubMedGoogle Scholar
  91. 91.
    Cade WT, Fantry LE, Nabar SR, Keyser RE. Decreased peak arteriovenous oxygen difference during treadmill exercise testing in individuals infected with the human immunodeficiency virus. Arch Phys Med Rehabil. 2003;84(11):1595–603.PubMedCrossRefGoogle Scholar
  92. 92.
    Oursler KK, Sorkin JD, Smith BA, Katzel LI. Reduced aerobic capacity and physical functioning in older HIV-infected men. AIDS Res Hum Retroviruses. 2006;22(11):1113–21.PubMedCrossRefGoogle Scholar
  93. 93.
    Somarriba G, Lopez-Mitnik G, Ludwig DA, Neri D, Schaefer N, Lipshultz SE et al. Physical fitness in children infected with the Human Immunodeficiency Virus: associations with highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2012. doi: 10.1089/AID.2012.0047.
  94. 94.
    Dudgeon WD, Phillips KD, Carson JA, Brewer RB, Durstine JL, Hand GA. Counteracting muscle wasting in HIV-infected individuals. HIV Med. 2006;7(5):299–310.PubMedCrossRefGoogle Scholar
  95. 95.
    Miller TL. A hospital-based exercise program to improve body composition, strength, and abdominal adiposity in 2 HIV-infected children. AIDS Read. 2007;17(9):450–2, 5, 8.PubMedGoogle Scholar
  96. 96.
    O'Brien K, Nixon S, Tynan AM, Glazier R. Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev. 2010(8):CD001796.Google Scholar
  97. 97.
    Glover EI, Phillips SM. Resistance exercise and appropriate nutrition to counteract muscle wasting and promote muscle hypertrophy. Curr Opin Clin Nutr Metab Care. 2010;13(6):630–4.PubMedCrossRefGoogle Scholar
  98. 98.
    Mesquita Soares TC, Galvao De Souza HA, De Medeiros Guerra LM, Pinto E, Pipolo Milan E, Moreira Dantas P, et al. Morphology and biochemical markers of people living with HIV/AIDS undergoing a resistance exercise program: clinical series. J Sports Med Phys Fitness. 2011;51(3):462–6.PubMedGoogle Scholar
  99. 99.
    • Farinatti PT, Borges JP, Gomes RD, Lima D, Fleck SJ. Effects of a supervised exercise program on the physical fitness and immunological function of HIV-infected patients. J Sports Med Phys Fitness. 2010;50(4):511–8. This aerobic and resistance training intervention study in adults with HIV concluded that a supervised exercise program was safe, improved muscular and aerobic fitness and has no negative effects on immunological function. PubMedGoogle Scholar
  100. 100.
    Fillipas S, Cherry CL, Cicuttini F, Smirneos L, Holland AE. The effects of exercise training on metabolic and morphological outcomes for people living with HIV: a systematic review of randomised controlled trials. HIV Clin Trials. 2010;11(5):270–82.PubMedCrossRefGoogle Scholar
  101. 101.
    Ogalha C, Luz E, Sampaio E, Souza R, Zarife A, Neto MG, et al. A randomized, clinical trial to evaluate the impact of regular physical activity on the quality of life, body morphology and metabolic parameters of patients with AIDS in Salvador, Brazil. J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S179–85.PubMedGoogle Scholar
  102. 102.
    •• Yarasheski KE, Cade WT, Overton ET, Mondy KE, Hubert S, Laciny E, et al. Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity. Am J Physiol Endocrinol Metab. 2011;300(1):E243–51. This study showed that exercise training augments the insulin response to pioglitazone (as assessed by hyperinsulinemic euglycemic clamp) and exercise training was associated with reduction in total body and limb fat. Exercise may be an important complementary treatment for patients requiring pharmacologic treatments for insulin resistance. PubMedCrossRefGoogle Scholar
  103. 103.
    UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic. 2010.Google Scholar
  104. 104.
    Miller TL, Somarriba G, Kinnamon DD, Weinberg GA, Friedman LB, Scott GB. The effect of a structured exercise program on nutrition and fitness outcomes in human immunodeficiency virus-infected children. AIDS Res Hum Retroviruses. 2010;26(3):313–9.PubMedCrossRefGoogle Scholar
  105. 105.
    Mansky KC. Aging, human immunodeficiency virus, and bone health. Clin Interv Aging. 2010;5:285–92.PubMedCrossRefGoogle Scholar
  106. 106.
    Somarriba G, Neri D, Schaefer N, Miller TL. The effect of aging, nutrition, and exercise during HIV infection. HIV AIDS (Auckl). 2010;2:191–201.Google Scholar
  107. 107.
    Yahiaoui A, McGough EL, Voss JG. Development of evidence-based exercise recommendations for older HIV-infected patients. J Assoc Nurses AIDS Care. 2012;23(3):204–19.PubMedCrossRefGoogle Scholar
  108. 108.
    Souza PM, Jacob-Filho W, Santarem JM, Zomignan AA, Burattini MN. Effect of progressive resistance exercise on strength evolution of elderly patients living with HIV compared to healthy controls. Clinics (Sao Paulo). 2011;66(2):261–6.PubMedCrossRefGoogle Scholar
  109. 109.
    Cade WT, Reeds DN, Overton ET, Herrero P, Waggoner AD, Davila-Roman VG, et al. Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis. Cardiovasc Diabetol. 2011;10:111.PubMedCrossRefGoogle Scholar
  110. 110.
    Ciccolo JT, Jowers EM, Bartholomew JB. The benefits of exercise training for quality of life in HIV/AIDS in the post-HAART era. Sports Med. 2004;34(8):487–99.PubMedCrossRefGoogle Scholar
  111. 111.
    Jong E, Oudhoff LA, Epskamp C, Wagener MN, van Duijn M, Fischer S, et al. Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era. AIDS. 2010;24(10):1387–405.PubMedCrossRefGoogle Scholar
  112. 112.
    Petroczi A, Hawkins K, Jones G, Naughton DP. HIV patient characteristics that affect adherence to exercise programmes: an observational study. Open AIDS J. 2010;4:148–55.PubMedCrossRefGoogle Scholar
  113. 113.
    • El-Bassel N, Jemmott 3rd JB, Landis JR, Pequegnat W, Wingood GM, Wyatt GE, et al. Intervention to influence behaviors linked to risk of chronic diseases: a multisite randomized controlled trial with African-American HIV-serodiscordant heterosexual couples. Arch Intern Med. 2011;171(8):728–36. This study is a multi-centered, multi-disciplinary team approach to improve multiple health behaviors in adults living with HIV. The authors concluded that this approach improved adherence to physical activity, improved healthy diet consumption and increased medical compliance.PubMedCrossRefGoogle Scholar
  114. 114.
    Rotheram-Borus MJ, Swendeman D, Lee SJ, Li L, Amani B, Nartey M. Interventions for families affected by HIV. Transl Behav Med. 2011;1(2):313–26.PubMedCrossRefGoogle Scholar
  115. 115.
    Weiss SM, Tobin JN, Antoni M, Ironson G, Ishii M, Vaughn A, et al. Enhancing the health of women living with HIV: the SMART/EST Women's Project. Int J Womens Health. 2011;3:63–77.PubMedGoogle Scholar
  116. 116.
    Ardoy DN, Fernandez-Rodriguez JM, Ruiz JR, Chillon P, Espana-Romero V, Castillo MJ, et al. Improving physical fitness in adolescents through a school-based intervention: the EDUFIT study. Rev Esp Cardiol. 2011;64(6):484–91.PubMedCrossRefGoogle Scholar
  117. 117.
    Snyder A, Colvin B, Gammack JK. Pedometer use increases daily steps and functional status in older adults. J Am Med Dir Assoc. 2011;12(8):590–4.PubMedCrossRefGoogle Scholar
  118. 118.
    Davies CA, Spence JC, Vandelanotte C, Caperchione CM, Mummery WK. Meta-analysis of internet-delivered interventions to increase physical activity levels. Int J Behav Nutr Phys Act. 2012;9(1):52.PubMedCrossRefGoogle Scholar
  119. 119.
    Hardy OT, Wiecha J, Kim A, Salas C, Briceno R, Moody K, et al. Effects of a multicomponent wellness intervention on dyslipidemia among overweight adolescents. J Pediatr Endocrinol Metab. 2012;25(1–2):79–82.PubMedGoogle Scholar
  120. 120.
    Lloyd JJ, Wyatt KM, Creanor S. Behavioural and weight status outcomes from an exploratory trial of the Healthy Lifestyles Programme (HeLP): a novel school-based obesity prevention programme. BMJ Open. 2012;2(3). doi: 10.1136/bmjopen-2011-000390.
  121. 121.
    Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423–34.PubMedCrossRefGoogle Scholar
  122. 122.
    Mutimura E, Crowther NJ, Cade TW, Yarasheski KE, Stewart A. Exercise training reduces central adiposity and improves metabolic indices in HAART-treated HIV-positive subjects in Rwanda: a randomized controlled trial. AIDS Res Hum Retroviruses. 2008;24(1):15–23.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Diana Botros
    • 1
  • Gabriel Somarriba
    • 1
  • Daniela Neri
    • 1
  • Tracie L. Miller
    • 1
  1. 1.Division of Pediatric Clinical Research, Department of Pediatrics (D820)University of Miami, Miller School of Medicine, Batchelor Children’s Research InstituteMiamiUSA

Personalised recommendations